Skip to main content

Advertisement

SpringerLink
Log in

Effects of Nanoliposomal and Pegylated Nanoliposomal Artemisinin in Treatment of Breast Cancer

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

This study is aimed to investigate the nanoliposomal artemisinin preparation, and its implementation on breast cancer cells. Side effects have been one of the common challenges of drug usage, as well as cancer treatment. In order to reduce such effects, nanotechnology has been a great help. Nanoliposomes are provided through reverse phase evaporation. In this method, certain proportions of phosphatidylcholine, cholesterol and artemisinin were mixed together. Besides, the obtained formulation was pegylated by using polyethylene glycol 2000 in order to increase its stability and solubility. The mean diameter of non-pegylated and pegylated liposomal artemisinin was determined by Zeta sizer system. The percent of drug released from liposome was performed by dialysis. The encapsulation efficiency of both formulations was estimated by spectrophotometry method. As a result, encapsulation and drug release of nanoliposomal formulation were more than the pegylation of the same formulation. In addition, this study indicated that cytotoxicity effect of pegylated nanoliposomal artemisinin was more, in comparison with nanoliposomal artemisinin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751–60.

    Article  PubMed  CAS  Google Scholar 

  2. Warner E. Clinical practice. Breast-cancer screening. N Engl J Med. 2011;365:1025–32.

    Article  PubMed  CAS  Google Scholar 

  3. Wang M, Thanou M. Targeting nanoparticles to cancer. Pharmacol Res. 2010;62:90–9.

    Article  PubMed  CAS  Google Scholar 

  4. Mohammed AR, Weston N, Coombes AG, Fitzgerald M, Perrie Y. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm. 2004;285:23–34.

    Article  PubMed  CAS  Google Scholar 

  5. Wagner A, Vorauer-Uhl K. Liposome technology for industrial purposes. J Drug Deliv. 2011;2011:591325.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lia T, Ho R. Trends and developments in liposome drug delivery systems. J Pharm Sci. 2001;90:667–80.

    Article  Google Scholar 

  7. Nakase I, Lai H, Singh NP, Sasaki T. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. Int J Pharm. 2008;354:28–33.

    Article  PubMed  CAS  Google Scholar 

  8. Lai H, Singh NP. Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. Cancer Lett. 2006;231:43–8.

    Article  PubMed  CAS  Google Scholar 

  9. Taylor WR, White NJ. Antimalarial drug toxicity: a review. Drug Saf. 2004;27:25–61.

    Article  PubMed  CAS  Google Scholar 

  10. Leonardi E, Gilvary G, White NJ, Nosten F. Severe allergic reactions to oral artesunate: a report of two cases. Trans R Soc Trop Med Hyg. 2001;95:182–3.

    Article  PubMed  CAS  Google Scholar 

  11. Zhang Z, Feng SS. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials. 2006;27:4025–33.

    Article  PubMed  CAS  Google Scholar 

  12. Chadwick J, Mercer AE, Park BK, Cosstick R, O’Neill PM. Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells. Bioorg Med Chem. 2009;17:1325–38.

    Article  PubMed  CAS  Google Scholar 

  13. Chen H, Sun B, Pan S, Jiang H, Sun X. Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo. Anticancer Drugs. 2009;20:131–40.

    Article  PubMed  Google Scholar 

  14. Lai HC, Singh NP, Sasaki T. Development of artemisinin compounds for cancer treatment. Investig New Drugs. 2013;31:230–46.

    Article  CAS  Google Scholar 

  15. Ning Z, Cheung CS, Fu J, Liu MA, Schnell MA. Experimental study of environmental tobacco smoke particles under actual indoor environment. Sci Total Environ. 2006;367:822–30.

    Article  PubMed  CAS  Google Scholar 

  16. Yatuv R, Robinson M, Dayan-Tarshish I, Baru M. The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia. Int J Nanomed. 2010;5:581–91.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Agricultural Biotechnology, Science and Research Branch, Islamic Azad University, Tehran, Iran

    Neda Dadgar & Sepideh Torabi

  2. Department of Pilot Nanobiotechnology, Pasteur Institute of Iran, No 358, 12 Farvardin Street, Jomhoori Avenue, 13169-43551, Tehran, Iran

    Maedeh Koohi Moftakhari Esfahani, Seyed Ebrahim Alavi & Azim Akbarzadeh

Authors
  1. Neda Dadgar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maedeh Koohi Moftakhari Esfahani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sepideh Torabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seyed Ebrahim Alavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Azim Akbarzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Seyed Ebrahim Alavi or Azim Akbarzadeh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dadgar, N., Koohi Moftakhari Esfahani, M., Torabi, S. et al. Effects of Nanoliposomal and Pegylated Nanoliposomal Artemisinin in Treatment of Breast Cancer. Ind J Clin Biochem 29, 501–504 (2014). https://doi.org/10.1007/s12291-013-0389-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-013-0389-x

Keywords

Search

Navigation